Healthcare provider profile · identity verified

Maria Yssa, M.D.

Family Practice · JACKSONVILLE, FL · NPI 1255583266

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	640	216
Amlodipine Besylate	Amlodipine Besylate	419	145
Rosuvastatin Calcium	Rosuvastatin Calcium	395	155
Levothyroxine Sodium	Levothyroxine Sodium	390	126
Lisinopril	Lisinopril	324	117
Losartan Potassium	Losartan Potassium	316	100
Metformin Hcl	Metformin Hcl	243	85
Omeprazole	Omeprazole	214	76
Metoprolol Tartrate	Metoprolol Tartrate	189	56
Tramadol Hcl	Tramadol Hcl	180	47
Gabapentin	Gabapentin	160	61
Hydrochlorothiazide	Hydrochlorothiazide	148	51
Metoprolol Succinate	Metoprolol Succinate	147	49
Alprazolam	Alprazolam	145	26
Albuterol Sulfate Hfa	Albuterol Sulfate	143	60
Pantoprazole Sodium	Pantoprazole Sodium	140	58
Trazodone Hcl	Trazodone Hcl	134	39
Fluticasone Propionate	Fluticasone Propionate	115	51
Furosemide	Furosemide	115	45
Carvedilol	Carvedilol	107	32
Tamsulosin Hcl	Tamsulosin Hcl	105	39
Clopidogrel	Clopidogrel Bisulfate	101	34
Azithromycin	Azithromycin	97	81
Prednisone	Prednisone	89	58
Meloxicam	Meloxicam	85	42
Alendronate Sodium	Alendronate Sodium	84	42
Simvastatin	Simvastatin	83	28
Duloxetine Hcl	Duloxetine Hcl	80	27
Zolpidem Tartrate	Zolpidem Tartrate	80	14
Potassium Chloride	Potassium Chloride	78	25
Sertraline Hcl	Sertraline Hcl	76	25
Ciprofloxacin Hcl	Ciprofloxacin Hcl	74	60
Januvia	Sitagliptin Phosphate	71	19
Montelukast Sodium	Montelukast Sodium	71	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	70	23
Eliquis	Apixaban	69	28
Baclofen	Baclofen	65	35
Clonazepam	Clonazepam	65	11
Temazepam	Temazepam	62	11
Hydralazine Hcl	Hydralazine Hcl	61	22
Fluoxetine Hcl	Fluoxetine Hcl	59	19
Nifedipine Er	Nifedipine	59	19
Glipizide	Glipizide	56	17
Ibuprofen	Ibuprofen	55	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	21
Ezetimibe	Ezetimibe	52	19
Meclizine Hcl	Meclizine Hcl	52	24
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	51	12
Novolog Flexpen	Insulin Aspart	49	17
Vitamin D2	Ergocalciferol (Vitamin D2)	49	34
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	48	13
Allopurinol	Allopurinol	44	17
Atenolol	Atenolol	44	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	11
Famotidine	Famotidine	42	16
Linzess	Linaclotide	42	13
Oxybutynin Chloride Er	Oxybutynin Chloride	40	19
Ozempic	Semaglutide	38	12
Spironolactone	Spironolactone	38	16
Ketoconazole	Ketoconazole	37	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	28
Paroxetine Hcl	Paroxetine Hcl	34	11
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Valsartan	Valsartan	33	12
Fenofibrate	Fenofibrate	31	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	31	13
Tizanidine Hcl	Tizanidine Hcl	31	14
Diclofenac Sodium	Diclofenac Sodium	30	19
Pravastatin Sodium	Pravastatin Sodium	30	11
Lovastatin	Lovastatin	29	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	suppressed
Memantine Hcl	Memantine Hcl	25	11
Finasteride	Finasteride	24	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Donepezil Hcl	Donepezil Hcl	22	12
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	13
Myrbetriq	Mirabegron	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	17
Buspirone Hcl	Buspirone Hcl	18	suppressed
Cephalexin	Cephalexin	18	16
Metformin Hcl Er	Metformin Hcl	18	suppressed
Repatha Sureclick	Evolocumab	18	suppressed
Fluconazole	Fluconazole	17	13
Jardiance	Empagliflozin	17	12
Mounjaro	Tirzepatide	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Prazosin Hcl	Prazosin Hcl	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Mupirocin	Mupirocin	15	13
Ondansetron Odt	Ondansetron	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	15	suppressed
Tresiba Flextouch U-200	Insulin Degludec	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Cefdinir	Cefdinir	14	11
Dropsafe Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Methylprednisolone	Methylprednisolone	14	13
Novolog	Insulin Aspart	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	13	suppressed
Naproxen	Naproxen	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	12	suppressed
Lactulose	Lactulose	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Topiramate	Topiramate	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Prolia	Denosumab	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error